# Shin-Etsu Chemical vs Sumco

> Unit: JPY millions (ratios in %)
> Periods: Shin-Etsu Chemical = FY ending Mar 2026, consolidated, J-GAAP / Sumco = FY ending Dec 2025, consolidated, J-GAAP
> Retrieved: 2026-09-30T19:01:54.763Z

| Metric | Shin-Etsu Chemical | Sumco |
| --- | ---: | ---: |
| Revenue | 2,573,969 | 409,670 |
| Operating income | 635,204 | 1,342 |
| Net income | 474,459 | -11,751 |
| COGS ratio | 65.8% | 86.7% |
| Operating margin | 24.7% | 0.3% |
| Net margin | 18.4% | -2.9% |
| FCF margin | 13.9% | -2.7% |
| Period | FY ending Mar 2026 | FY ending Dec 2025 |
| Source | S100YE9I | S100XRR5 |

## Five-axis industry profile

Each axis shows a rank within that company's primary industry, so peer groups may differ. Missing values are labeled unavailable; no combined score is calculated. Industry rank is not an investment recommendation.

| Axis | Shin-Etsu Chemical | Sumco |
| --- | ---: | ---: |
| Revenue growth | 80.4 (23 peers) | 45.7 (23 peers) |
| Profitability | 89.6 (24 peers) | 2.1 (24 peers) |
| Cash conversion | 43.8 (24 peers) | 97.9 (24 peers) |
| Efficiency | 18.8 (24 peers) | 6.3 (24 peers) |
| Financial strength | — | — |

## Company details

- https://vizora.meequs.com/en/company/shin-etsu-chemical/md
- https://vizora.meequs.com/en/company/sumco/md

## Definitions

- Amounts are in millions of JPY (rounded). The period is stated in each table heading
- Operating margin = operating income ÷ revenue. Net income is attributable to owners of the parent when disclosed
- Free cash flow (FCF) = operating cash flow − capital expenditure
- ¥100 model = breakdown per ¥100 of revenue (rounded so parts sum to 100)
- Segment revenues include inter-segment sales and may not sum to consolidated revenue
- Source IDs are EDINET document IDs (docID). "算出" (derived) means computed from other disclosed values
- All figures are extracted mechanically from filings. AI-written text never generates figures
- Source: company filings submitted to EDINET (Financial Services Agency of Japan). Figures were extracted, edited and processed, and charts and text were created, by Vizora — not by the FSA (used under the Public Data License v1.0).